Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
  6. News
  7. Summary
    600196   CNE000000X38

SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.

(600196)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Fosun Pharma Buys Majority Stake in Vaccine Maker; Shares Slide 4%

10/27/2021 | 01:18am EST


ę MT Newswires 2021
All news about SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
12/02SHANGHAI FOSUN PHARMACEUTICAL : Overseas regulatory announcement (h shares)
PU
12/01SHANGHAI FOSUN PHARMACEUTICAL : Monthly return of equity issuer on movements in securities..
PU
12/01SHANGHAI FOSUN PHARMACEUTICAL : Voluntary announcement - lapse of implementation period of..
PU
11/26SoftBank in investment talks with Chinese mRNA vaccine firm Abogen - sources
RE
11/26SHANGHAI FOSUN PHARMACEUTICAL : Overseas regulatory announcement (h shares)
PU
11/25Fosun Pharma Forms Two Funds to Invest in New Drug-Related Projects
MT
11/24SHANGHAI FOSUN PHARMACEUTICAL : Voluntary announcement regarding the establishment of inve..
PU
11/24SHANGHAI FOSUN PHARMACEUTICAL : Connected transaction formation of partnership
PU
11/24SHANGHAI FOSUN PHARMACEUTICAL : Revision of annual caps of continuing connected transactio..
PU
11/19China's BioKangtai begins first shipment of AstraZeneca's COVID-19 shot
RE
More news
Analyst Recommendations on SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
More recommendations
Financials
Sales 2021 36 295 M 5 694 M 5 694 M
Net income 2021 4 480 M 703 M 703 M
Net Debt 2021 14 452 M 2 267 M 2 267 M
P/E ratio 2021 30,7x
Yield 2021 0,86%
Capitalization 123 B 19 367 M 19 376 M
EV / Sales 2021 3,80x
EV / Sales 2022 3,15x
Nbr of Employees 32 258
Free-Float 58,1%
Chart SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Duration : Period :
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Last Close Price 53,07 CNY
Average target price 68,65 CNY
Spread / Average Target 29,4%
EPS Revisions
Managers and Directors
Xiao Hui Guan Executive President & Chief Financial Officer
Yu Qing Chen Co-President
Ke Xin Wang Co-President
Dong Ming Li Co-President
Yi Fang Wu Chairman